| Date Filed | Type | Description |
| 06/16/2023 |
4
| Cadoret-Manier Onaiza (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/16/2023 |
4
| Cadoret-Manier Onaiza (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 12,755 shares
@ $0
Granted 49,237 options to buy
@ $3.92, valued at
$193k
|
|
| 04/27/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/07/2023 |
4
| Cadoret-Manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 4,140 shares
@ $0
Sold 1,451 shares
@ $40.6595, valued at
$59k
|
|
| 01/19/2023 |
4
| Cadoret-Manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 3,748 shares
@ $39.5473, valued at
$148.2k
Exercised 10,197 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| Cadoret-Manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 16,216 options to buy
@ $0
Granted 19,460 options to buy
@ $0 |
|
| 01/12/2023 |
4
| Cadoret-Manier Onaiza (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 12,880 options to buy
@ $34.16, valued at
$440k
|
|
| 01/12/2023 |
3
| Cadoret-Manier Onaiza (Director) has filed a Form 3 on Ventyx Biosciences, Inc. |
| 01/05/2023 |
4
| Cadoret-Manier Onaiza (EVP, Chf GL Pdt Str & Oper Ofc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 25,946 options to buy
@ $37.58, valued at
$975.1k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| Cadoret-Manier Onaiza (EVP, Chf Pdt Str & Oper Ofc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,960 shares
@ $41.01, valued at
$80.4k
Exercised 5,667 restricted stock units
@ $0 |
|
| 01/20/2022 |
4
| Cadoret-Manier Onaiza (EVP, Chf Corp Dev and Cml Offc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,305 shares
@ $30.12, valued at
$69.4k
Exercised 6,057 restricted stock units
@ $0 |
|
| 01/19/2022 |
4
| Cadoret-Manier Onaiza (EVP, Chf Corp Dev and Cml Offc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 12,419 options to buy
@ $0
Granted 16,559 options to buy
@ $0 |
|
| 01/05/2022 |
4
| Cadoret-Manier Onaiza (EVP, Chf Corp Dev and Cml Offc) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 33,118 options to buy
@ $32.6, valued at
$1.1M
|
|
| 09/02/2021 |
4
| Cadoret-Manier Onaiza (Chief Corp Dev and Cml Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 431 shares
@ $33.796, valued at
$14.6k
|
|
| 06/21/2021 |
4
| Cadoret-Manier Onaiza (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 32,765 options to buy
@ $7.31, valued at
$239.5k
|
|
| 04/19/2021 |
4
| Cadoret-Manier Onaiza (Chief Corp Dev and Cml Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,960 shares
@ $41.03, valued at
$80.4k
Exercised 5,667 restricted stock units
@ $0 |
|
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Cadoret-Manier Onaiza (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 6,155 shares
@ $0 |
|
| 04/17/2020 |
4/A
| Cadoret-Manier Onaiza (Chief Corp Dev and Cml Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 22,667 restricted stock units
@ $0 |
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/17/2020 |
4
| Cadoret-Manier Onaiza (Chief Corp Dev and Cml Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 22,667 restricted stock units
@ $0 |
|
| 01/13/2020 |
4
| Cadoret-Manier Onaiza (Chief Corp Development Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Granted 51,000 options to buy
@ $63.27, valued at
$3.2M
|
|
| 01/13/2020 |
3
| Cadoret-Manier Onaiza (Chief Corp Dev and Cml Officer) has filed a Form 3 on IONIS PHARMACEUTICALS INC |